Pantoprazol Krka (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Krka, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pantoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Krka is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): Improves the healing of the esophageal lining by reducing acid exposure. - Erosive esophagitis: Provides the primary healing of erosions in the esophagus by lower ‑    . - Peptic ulcer disease (duoden    . -  . -  . -   . -    …  …  ....   …  …  ...